company background image
AIH

Aesthetic Medical International Holdings GroupNasdaqGM:AIH Stock Report

Market Cap

US$78.1m

7D

-7.0%

1Y

-42.3%

Updated

26 Nov, 2021

Data

Company Financials
AIH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

AIH Stock Overview

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services.

Price History & Performance

Summary of all time highs, changes and price drops for Aesthetic Medical International Holdings Group
Historical stock prices
Current Share PriceUS$3.31
52 Week HighUS$11.24
52 Week LowUS$3.31
Beta-0.85
1 Month Change-20.24%
3 Month Change-21.75%
1 Year Change-42.33%
3 Year Changen/a
5 Year Changen/a
Change since IPO-67.00%

Recent News & Updates

Shareholder Returns

AIHUS HealthcareUS Market
7D-7.0%-1.4%-0.7%
1Y-42.3%23.3%24.7%

Return vs Industry: AIH underperformed the US Healthcare industry which returned 23.3% over the past year.

Return vs Market: AIH underperformed the US Market which returned 24.7% over the past year.

Price Volatility

Is AIH's price volatile compared to industry and market?
AIH volatility
AIH Average Weekly Movement6.3%
Healthcare Industry Average Movement6.3%
Market Average Movement6.0%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market2.2%

Stable Share Price: AIH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: AIH's weekly volatility has decreased from 13% to 6% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19971,665Pengwu Zhouhttps://ir.aihgroup.net

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services.

Aesthetic Medical International Holdings Group Fundamentals Summary

How do Aesthetic Medical International Holdings Group's earnings and revenue compare to its market cap?
AIH fundamental statistics
Market CapCN¥499.27m
Earnings (TTM)-CN¥360.04m
Revenue (TTM)CN¥1.08b

0.5x

P/S Ratio

-1.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AIH income statement (TTM)
RevenueCN¥1.08b
Cost of RevenueCN¥407.91m
Gross ProfitCN¥670.47m
ExpensesCN¥1.03b
Earnings-CN¥360.04m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-15.26
Gross Margin62.17%
Net Profit Margin-33.39%
Debt/Equity Ratio228.3%

How did AIH perform over the long term?

See historical performance and comparison

Valuation

Is Aesthetic Medical International Holdings Group undervalued compared to its fair value and its price relative to the market?

3.41x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate AIH's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate AIH's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: AIH is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: AIH is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AIH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AIH is overvalued based on its PB Ratio (3.6x) compared to the US Healthcare industry average (2.9x).


Future Growth

How is Aesthetic Medical International Holdings Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aesthetic Medical International Holdings Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Aesthetic Medical International Holdings Group performed over the past 5 years?

-27.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AIH is currently unprofitable.

Growing Profit Margin: AIH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AIH is unprofitable, and losses have increased over the past 5 years at a rate of 27.8% per year.

Accelerating Growth: Unable to compare AIH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AIH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (32.5%).


Return on Equity

High ROE: AIH has a negative Return on Equity (-439.85%), as it is currently unprofitable.


Financial Health

How is Aesthetic Medical International Holdings Group's financial position?


Financial Position Analysis

Short Term Liabilities: AIH's short term assets (CN¥156.1M) do not cover its short term liabilities (CN¥324.0M).

Long Term Liabilities: AIH's short term assets (CN¥156.1M) do not cover its long term liabilities (CN¥248.3M).


Debt to Equity History and Analysis

Debt Level: AIH's net debt to equity ratio (181.5%) is considered high.

Reducing Debt: Insufficient data to determine if AIH's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if AIH has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if AIH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Aesthetic Medical International Holdings Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AIH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AIH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AIH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AIH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AIH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average board tenure


CEO

Pengwu Zhou (66 yo)

no data

Tenure

Dr. Pengwu Zhou is the Founder, Chairman of the board of directors and Chief Executive Officer at Aesthetic Medical International Holdings Group Limited and is its Co-Founder. Dr. Zhou has been a registere...


Board Members

Experienced Board: AIH's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Aesthetic Medical International Holdings Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Aesthetic Medical International Holdings Group Limited
  • Ticker: AIH
  • Exchange: NasdaqGM
  • Founded: 1997
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$78.109m
  • Shares outstanding: 23.60m
  • Website: https://ir.aihgroup.net

Number of Employees


Location

  • Aesthetic Medical International Holdings Group Limited
  • 1122 Nanshan Boulevard
  • Nanshan District
  • Shenzhen
  • Guangdong Province
  • 518052
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/26 23:01
End of Day Share Price2021/11/26 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.